Butaselen

卟硒啉

Report date: 2025/03/06 14:53:10
NMEFirst In Class

Base Information

Drug NameButaselen
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThioredoxin reductase inhibitors
TargetsThioredoxin reductase
Therapy Area/IndicationsSolid tumoursHamman-Rich SyndromePulmonary Fibrosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Yuanxi Medicine Corp
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Yuanxi Medicine Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursHamman-Rich SyndromePulmonary Fibrosis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A